Rhythm Pharmaceuticals logo

Rhythm Pharmaceuticals Share Price Today

(NASDAQ: RYTM)

Rhythm Pharmaceuticals share price is $55.21 & ₹4,765.40 as on 20 Mar 2025, 2.30 'hrs' IST

$55.21

2.92

(5.58%)

Market is closed - opens 7 PM, 20 Mar 2025

View live Rhythm Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Rhythm Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Rhythm Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Rhythm Pharmaceuticals share price movements

  • Today's Low: $52.20
    Today's High: $55.86

    Day's Volatility :6.54%

  • 52 Weeks Low: $35.17
    52 Weeks High: $68.58

    52 Weeks Volatility :48.72%

Rhythm Pharmaceuticals (RYTM) Returns

PeriodRhythm Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-5.75%
7.7%
0.0%
6 Months
-4.14%
-5.8%
0.0%
1 Year
31.78%
0.7%
0.0%
3 Years
364.8%
7.2%
-15.2%

Rhythm Pharmaceuticals (RYTM) Key Statistics

in dollars & INR

Previous Close
$52.29
Open
$52.25
Today's High
$55.855
Today's Low
$52.2
Market Capitalization
$3.3B
Today's Volume
$391.9K
52 Week High
$68.58
52 Week Low
$35.17
Revenue TTM
$130.1M
EBITDA
$-263.9M
Earnings Per Share (EPS)
$-4.34
Profit Margin
-200.27%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-155.91%

How to invest in Rhythm Pharmaceuticals Stock (RYTM) from India?

It is very easy for Indian residents to invest directly in Rhythm Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rhythm Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rhythm Pharmaceuticals or RYTM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rhythm Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rhythm Pharmaceuticals shares which would translate to 0.016 fractional shares of Rhythm Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rhythm Pharmaceuticals, in just a few clicks!

Returns in Rhythm Pharmaceuticals (RYTM) for Indian investors in Rupees

The Rhythm Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rhythm Pharmaceuticals investment value today

Current value as on today

₹1,43,156

Returns

₹43,156

(+43.16%)

Returns from Rhythm Pharmaceuticals Stock

₹39,138 (+39.14%)

Dollar Returns

₹4,018 (+4.02%)

Indian investors sentiment towards Rhythm Pharmaceuticals (RYTM)

-31%

Period: Feb 17, 2025 to Mar 19, 2025. Change in 30 Days versus previous period

Search interest for Rhythm Pharmaceuticals Stock from India on INDmoney has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Rhythm Pharmaceuticals

  • BlackRock Inc

    10.99%

  • PRIMECAP Management Company

    10.39%

  • RA Capital Management, LLC

    9.62%

  • Baker Bros Advisors LP

    9.62%

  • Perceptive Advisors LLC

    5.82%

  • Vanguard Group Inc

    5.45%

Analyst Recommendation on Rhythm Pharmaceuticals

Buy

    93%Buy

    6%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Rhythm Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
14
14
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Rhythm Pharmaceuticals Stock (RYTM)

What analysts predicted

Upside of 36.0%

Target:

$75.08

Current:

$55.21

Insights on Rhythm Pharmaceuticals Stock (Ticker Symbol: RYTM)

  • Price Movement

    In the last 3 years, RYTM stock has moved up by 364.8%
  • Increasing Revenue

    Revenue is up for the last 10 quarters, 4.28M → 41.83M (in $), with an average increase of 20.8% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -44.97M → -43.29M (in $), with an average increase of 3.9% per quarter
  • RYTM vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.9% return, outperforming this stock by 31.2%
  • Price to Sales

    ForRYTM every $1 of sales, investors are willing to pay $25.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.4 for every $1 of sales.

Rhythm Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Rhythm Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Rhythm Pharmaceuticals (RYTM) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Rhythm Pharmaceuticals Inc logo
-9.14%
-4.14%
31.78%
364.8%
167.74%
Regeneron Pharmaceuticals, Inc. logo
-2.21%
-42.19%
-31.23%
-4.07%
45.94%
Beone Medicines Ltd logo
9.77%
31.62%
54.1%
45.52%
104.52%
Vertex Pharmaceuticals Incorporated logo
10.85%
7.18%
24.29%
104.68%
153.32%
Alnylam Pharmaceuticals, Inc. logo
-2.28%
-11.59%
65.08%
50.4%
146.62%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Rhythm Pharmaceuticals Inc logo
NA
NA
NA
-2.44
-1.56
-0.46
NA
0.35
Regeneron Pharmaceuticals, Inc. logo
17.7
17.7
1.0
42.64
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.45
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.43
18.06
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.52
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Rhythm Pharmaceuticals Inc logo
Buy
$3.3B
167.74%
NA
-200.27%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.2B
45.94%
17.7
31.07%
Beone Medicines Ltd logo
NA
$28.4B
104.52%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$131.9B
153.32%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$32.8B
146.62%
NA
-12.37%

Rhythm Pharmaceuticals Dividend announcements

  • Rhythm Pharmaceuticals Earnings

    Rhythm Pharmaceuticals’s price-to-earnings ratio stands at None

About Rhythm Pharmaceuticals

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. The company was founded in 2008 and is headquartered in Boston, Massachusetts.
Organization
Rhythm Pharmaceuticals
Employees
283
CEO
Dr. David P. Meeker M.D.
Industry
Health Technology

Management People of Rhythm Pharmaceuticals

NameTitle
Dr. David P. Meeker M.D.
Chairman, President & CEO
Mr. Hunter C. Smith M.B.A.
CFO & Treasurer
Mr. Joseph Shulman
Chief Technical Officer
Mr. Yann Mazabraud
Executive VP & Head of International
Ms. Jennifer Lee
Executive VP & Head of North America
Mr. Christopher P. German
Corporate Controller & Principal Accounting Officer
Dr. Alastair Garfield Ph.D.
Chief Scientific Officer
Mr. David Connolly
Head of Investor Relations & Corporate Communications
Mr. Jim Flaherty
Senior VP & General Counsel
Ms. Sarah Ryan
Vice President of Sales & Marketing

Important FAQs about investing in RYTM Stock from India :

What is Rhythm Pharmaceuticals share price today?

Rhythm Pharmaceuticals share price today stands at $55.21, Open: $52.25 ; Previous Close: $52.29 ; High: $55.86 ; Low: $52.20 ; 52 Week High: $68.58 ; 52 Week Low: $35.17.

The stock opens at $52.25, after a previous close of $52.29. The stock reached a daily high of $55.86 and a low of $52.20, with a 52-week high of $68.58 and a 52-week low of $35.17.

Can Indians buy Rhythm Pharmaceuticals shares?

Yes, Indians can invest in the Rhythm Pharmaceuticals (RYTM) from India.

With INDmoney, you can buy Rhythm Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Rhythm Pharmaceuticals at zero transaction cost.

How can I buy Rhythm Pharmaceuticals shares from India?

It is very easy to buy Rhythm Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rhythm Pharmaceuticals (RYTM) be purchased?

Yes, you can buy fractional shares of Rhythm Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Rhythm Pharmaceuticals stocks?

To start investing in Rhythm Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Rhythm Pharmaceuticals Stock (RYTM)?

Today’s highest price of Rhythm Pharmaceuticals (RYTM) is $55.86.

Today’s lowest price of Rhythm Pharmaceuticals (RYTM) is $52.20.

What is today's market capitalisation of Rhythm Pharmaceuticals?

Today's market capitalisation of Rhythm Pharmaceuticals RYTM is 3.3B

What is the 52 Week High and Low Range of Rhythm Pharmaceuticals Stock (RYTM)?

  • 52 Week High

    $68.58

  • 52 Week Low

    $35.17

What are the historical returns of Rhythm Pharmaceuticals (RYTM)?

  • 1 Month Returns

    -9.14%

  • 3 Months Returns

    -4.14%

  • 1 Year Returns

    31.78%

  • 5 Years Returns

    167.74%

Who is the Chief Executive Officer (CEO) of Rhythm Pharmaceuticals ?

Dr. David P. Meeker M.D. is the current Chief Executive Officer (CEO) of Rhythm Pharmaceuticals.